COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

BACKGROUND: The are conflicting reports on the effects of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) continued treatment on clinical outcomes in COVID-19 patients. MATERIAL AND METHODS: Patients presented with symptoms suggestive of COVID-19 infection w...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ahmed Nafakhi, Ihsan Rabeea, Rasha AL-Darraji, Hussein Nafakhi, Ahmed Mechi, Alhan Al-khalidi
Format:	Artigo
Idioma:	Inglês
Publicat:	Via Medica 2022-03-01
Col·lecció:	Arterial Hypertension
Matèries:	COVID-19 ARB ACEI outcome long term
Accés en línia:	https://journals.viamedica.pl/arterial_hypertension/article/view/87525
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!